Author Correction: Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcoma

Author Correction: Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcoma

Saved in:

Bibliographic Details
Main Authors:	Andrew Haskell, Simin Pan, Robert Reese, Anthony Powers, Megan G. Lopez, Sebastian Lomeli, Christopher Story, Joshua Benton, J. Chris Blazier, Roland Kaunas, Carl A. Gregory
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-025-91472-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcoma
by: Andrew Haskell, et al.
Published: (2025-01-01)

Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
by: Yuan Li, et al.
Published: (2021-03-01)

Plasma Dickkopf-1 Levels Are Associated with Chronic Kidney Disease
by: Yu-Hsuan Li, et al.
Published: (2025-04-01)

Diffuse pleural metastases of osteosarcoma detected by bone scan
by: André Ribeiro, et al.
Published: (2020-07-01)

Growth hormone receptor promotes osteosarcoma cell growth and metastases
by: Mo Cheng, et al.
Published: (2020-01-01)

STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis
by: Pradeep Shrestha, et al.
Published: (2025-06-01)

Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo
by: Yanhao Ji, et al.
Published: (2024-11-01)

Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases
by: Hans Gelderblom, et al.
Published: (2024-08-01)

Locked nucleic acid-modified antisense oligonucleotides attenuate scar hyperplasia through targeted inhibition of CTGF
by: Jinhe Li, et al.
Published: (2025-08-01)

The effect of 1,25(OH)2D3 on Dickkopf-1 methylation in colorectal cancer
by: Hongyan Sun, et al.
Published: (2025-03-01)

Correlation of Circulating Dickkopf-1 Level with Sonographic Findings and Radiographic Grading in Primary Knee Osteoarthritis
by: Adel Ibrahim Azzam, et al.
Published: (2025-01-01)

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
by: Onno Kranenburg, et al.
Published: (2022-12-01)

CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma
by: Lei Shi, et al.
Published: (2025-04-01)

Renal Metastases of a Femur Osteosarcoma: A Case Report and a Review of the Literature
by: Yousra Akasbi, et al.
Published: (2012-01-01)

Serum Dickkopf-1 Level in Postmenopausal Females: Correlation with Bone Mineral Density and Serum Biochemical Markers
by: Sahar Fathi Ahmed, et al.
Published: (2013-01-01)

Urinary Dickkopf-Related Protein 3—A Potential Long-Term Biomarker for Progressive CKD in Children
by: Katalin Dittrich, et al.
Published: (2025-05-01)

Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01)

Synthesis, in vitro evaluation and computational modelling of benzene sulfonamide derivatives as Dickkopf 1 inhibitors for anticancer drug development
by: Muhammad Sajjad Bilal, et al.
Published: (2025-07-01)

Urinary Dickkopf‐3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure
by: Dennis Pieper, et al.
Published: (2024-12-01)

Urinary Dickkopf-3 Reflects Disease Severity and Predicts Short-Term Kidney Function Decline in Renal Ciliopathies
by: Mareike Dahmer-Heath, et al.
Published: (2025-01-01)

Prognostic nomogram for overall survival in pediatric osteosarcoma with pulmonary metastases: a SEER database analysis
by: Jiaxiang Tang, et al.
Published: (2025-04-01)

Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
by: Alexander Constantinides, et al.
Published: (2025-09-01)

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01)

Tofersen and other antisense oligonucleotides in ALS
by: Albert Ludolph, et al.
Published: (2025-01-01)

Landscape of antisense genes in the human genome and identification of new human hepatic antisense RNAs by long-read sequencing
by: Juan Jose Rojo-Carrillo, et al.
Published: (2024-11-01)

Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model.
by: Zvia Agur, et al.
Published: (2011-01-01)

Evaluating Dickkopf-1 as a biomarker: insights into periodontitis, rheumatoid arthritis, and their comorbidity—a systematic review and meta-analysis
by: Bawatharani Maharavi, et al.
Published: (2025-07-01)

Molecular Signalling in Hepatocellular Carcinoma: Role of and Crosstalk among Wnt/β-Catenin, Sonic Hedgehog, Notch and Dickkopf-1
by: Alexandros Giakoustidis, et al.
Published: (2015-01-01)

Blocking TLR2 activity attenuates pulmonary metastases of tumor.
by: Hong-Zhen Yang, et al.
Published: (2009-08-01)

Development of Antisense Tools to Study Bodo saltans and Its Intracellular Symbiont
by: Mastaneh Ahrar, et al.
Published: (2025-04-01)

An update in the management of spinal metastases
by: Andrei F. Joaquim, et al.
Published: (2015-09-01)

PERSPECTIVES OF ANTISENSE GENE THERAPY IN ORGAN TRANSPLANTATION
by: O. N. Reznik, et al.
Published: (2013-03-01)

Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature
by: Ulrike Michaela Pirker-Frühauf, et al.
Published: (2013-01-01)

CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects
by: Jia-Wen Wang, et al.
Published: (2025-07-01)

Retraction: Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor.
by: PLOS One Editors
Published: (2025-01-01)

Retraction: Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor
Published: (2025-01-01)

Antisense oligonucleotides targeting IRF4 alleviate psoriasis
by: Yanxia Yu, et al.
Published: (2025-07-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024-12-01)

Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
by: Heather Lin, et al.
Published: (2024-07-01)